NCT06923709View on ClinicalTrials.gov

Beneficial Effect of Amiloride on Progression of Chronic Kidney Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

November 1, 2025

Conditions
Chronic Kidney Disease(CKD)Proteinuria
Interventions
DRUG

amiloride

5mg twice daily for 7 days

DRUG

Placebo

1 tablet twice daily for 7 days

Trial Locations (1)

5000

RECRUITING

Department of Nephrology, Odense University Hospital, Odense

All Listed Sponsors
lead

Odense University Hospital

OTHER